StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.22−0.16 (-11.59%)

Close on Nov 17, 2026Market cap $27.65MP/E –Yield –

BioHarvest Sciences r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $5.31M, up 10.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.31M+10.7%
FY2024Dec 31, 2024$4.80M+42.4%
FY2023Dec 31, 2023$3.37M–

More BioHarvest Sciences figures

See a number that looks wrong?